Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CTI BCS 2100

This article was originally published in The Gray Sheet

Executive Summary

Breast imaging system will be evaluated in a new clinical trial at Massachusetts General Hospital beginning in the fall, the firm announces Aug. 21. The study will look at the non-invasive thermal imaging system as a follow-up to abnormal mammograms to distinguish between benign and malignant tumors. A PMA for the device is scheduled for review by FDA's Radiological Devices advisory panel on Oct. 16 (1"The Gray Sheet" July 29, 2002, p. 16)...
Advertisement

Related Content

CTI Thermal Breast Imaging Device Will Go Before FDA Panel In Mid-October
CTI Thermal Breast Imaging Device Will Go Before FDA Panel In Mid-October
Advertisement
UsernamePublicRestriction

Register

MT017051

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel